[Combination therapy of Buschke-Löwenstein tumor with CO2 laser and interferon-alpha].
Pinzger
G
G
Univers.-Klinik f. Frauenheilk, Innsbruck.
Müller-Holzner
E
E
Wartusch
B
B
Baumgartner
P
P
Zeimet
A
A
Weiss
D
D
Ruth
N R
NR
Marth
C
C
Kirchler
H
H
Heim
K
K
D000368:Aged; D003131:Combined Modality Therapy; D003218:Condylomata Acuminata / Q000628:therapy*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D053685:Laser Therapy; D027383:Papillomaviridae; D011994:Recombinant Proteins; D014412:Tumor Virus Infections / Q000628:therapy*; D014846:Vulvar Neoplasms / Q000628:therapy*
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
Kombinationstherapie des Buschke-Löwenstein-Tumors mit CO2-Laser und Interferon-Alpha.